Anna Boguszewska-Czubara

Dr. Anna Boguszewska-Czubara

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2014 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
BBBarbara Budzynska
Barbara Budzynska
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
MKMarta Kruk-Slomka
Marta Kruk-Slomka
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
AMAgnieszka Michalak
Agnieszka Michalak
GBGrazyna Biala
Grazyna Biala
Rationale Imperatorin, a naturally occurring furanocoumarin, inactivates gamma-aminobutyric acid transaminase and inhibits acetylcholinesterase activity. Objectives The purpose of our experiment was to examine the influence of imperatorin on cognitive impairment and oxidative stress in the brain induced by scopolamine in male Swiss mice. Methods In the present studies, we used scopolamine-invoke memory deficit measured in passive avoidance (PA) paradigm as an animal model of Alzheimer disease (AD). Results Our finding revealed that imperatorin administered acutely at the doses of 5 and 10 mg/kg prior to the injection of scopolamine (1 mg/kg) improved memory acquisition and consolidation impaired by scopolamine. Furthermore, repeatable (7 days, twice daily) administration of the highest dose of imperatorin (10 mg/kg) significantly attenuated the effects of scopolamine on memory acquisition, whereas the doses of 5 and 10 mg/kg of this furanocoumarin were effective when memory consolidation was measured. Imperatorin, administered with scopolamine, increased antioxidant enzymes activity and decreased concentration of malondiamide, an indicator of lipid peroxidation level. Conclusions These results demonstrate that imperatorin may offer protection against scopolamine-induced memory impairments and possesses antioxidant properties, thus after further preclinical and clinical studies this compound may provide an interesting approach in pharmacotherapy, as well as prophylactics of AD.

17 July 2014 in Reaction Kinetics, Mechanisms and Catalysis
Verified
Journal Article
Open access
PDF file
Radomir JasinskiRadomir Jasinski
Radomir Jasinski
MKMagdalena Kubik
Magdalena Kubik
Agnieszka ŁapczukAgnieszka Łapczuk
Agnieszka Łapczuk
Agnieszka Kącka-ZychAgnieszka Kącka-Zych
Agnieszka Kącka-Zych
EDEwa Dresler
Ewa Dresler
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
The mechanistic aspects of the hetero Diels–Alder reactions between strongly electrophilic (E)-2-aryl-1-cyano-1-nitroethenes and ethyl vinyl ether have been analyzed on the basis of kinetic experimental results as well as quantum chemical simulations of reaction paths. These reactions may theoretically proceed via one step or stepwise, zwitterionic mechanism. It was found that the conversion of addends into adducts carried out via polar, but not zwitterionic mechanism. This is confirmed by kinetic substituent and solvent effects. Subsequently, a detailed analysis of internal reaction coordinate trajectories shows that the title reactions should be considered as examples of “two-stage one-step” cycloadditions according to Domingo terminology.

29 January 2018 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
BBBarbara Budzynska
Barbara Budzynska
GBGrazyna Biala
Grazyna Biala
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara

1 October 2013 in Physiology & Behavior
Verified
Journal Article
Closed access
BBBarbara Budzynska
Barbara Budzynska
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
MKMarta Kruk-Slomka
Marta Kruk-Slomka
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
AMAgnieszka Michalak
Agnieszka Michalak
KGKazimierz Głowniak
Kazimierz Głowniak

30 December 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Przemysław JodłowskiPrzemysław Jodłowski
Przemysław Jodłowski
GKGrzegorz Kurowski
Grzegorz Kurowski
ŁKŁukasz Kuterasiński
Łukasz Kuterasiński
MSMaciej Sitarz
Maciej Sitarz
PJPiotr Jeleń
Piotr Jeleń
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara

18 January 2016 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
GBGrażyna Biała
Grażyna Biała
KPK. Pekala
K. Pekala
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
AMAgnieszka Michalak
Agnieszka Michalak
MKM. Kruk-Slomka
M. Kruk-Slomka
BBB. Budzynska
B. Budzynska
Nicotine, the main component of tobacco smoke, exerts influence on mood, and contributes to physical and psychological dependence. Taking into account frequent concomitance of nicotine abuse and stress, we aimed to research behavioral and biochemical effects associated with nicotine administration in combination with chronic unpredictable mild stress (CUMS). Mice were submitted to the procedure of CUMS for 4 weeks, 2 h per day. Our results revealed that CUMS-exposed animals exhibited behavioral alteration like anxiety disorders in the elevated plus maze (EPM) test, the disturbances in memory in the passive avoidance (PA) test and depressive effects in the forced swim test (FST). Moreover, nicotine (0.05–0.5 mg/kg), after an acute or subchronic administration decreased stress-induced depression- and anxiety-like effect as well as memory deficit. Administration of metyrapone (50 mg/kg), a glucocorticosteroid antagonist, alleviated the depressive effect induced by the CUMS. The biochemical experiments showed decreased values of the total antioxidant status (TAS), activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) with simultaneously increased in malondialdehyde (MDA) concentration in mice submitted to the CUMS. The same effects were observed after an acute and subchronic nicotine administration within all examined brain structures (i.e., hippocampus, cortex, and cerebellum) and in the whole brain in non-stressed and stressed mice confirming pro-oxidative effect of nicotine. Our study contributes to the understanding of behavioral and biochemical mechanisms involved in stress-induced disorders such as depression, anxiety and memory disturbances as well as dual nicotine-stress interactions on the basis of the development of nicotine dependence.